FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence